3 hours Bristol-Myers Squibb (NYSE:BMY) Rating Reiterated by Cantor FitzgeraldMarketBeat
Cantor Fitzgerald reaffirmed a “neutral” rating and set a $50.00 price target on shares of Bristol-Myers Squibb in a research report on Friday.
Bristol · Bristol-Myers Squibb (BMY) · NYSE · Science
X